EV/EBITDA
0.51
+0.09+21.43%
Thu, 27 Feb 2025 23:24:56 GMT
Summary
- As of February 28, 2025, LXEO EV/EBITDA is 0.51, with a rise of +0.09 (+21.43%) during the most recent trading day.
- Over the past year, LXEO EV/EBITDA has increased by +5.25 (+110.76%).
- LXEO EV/EBITDA is now -10.53% below its all-time high of 0.57.
Performance
LXEO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
LXEO EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +21.4% | -22.6% | -7.1% |
1 m1 month | +210.9% | -210.9% | -44.2% |
3 m3 months | +137.2% | -137.2% | -60.6% |
6 m6 months | +119.7% | -122.2% | -71.1% |
ytdytd | +160.7% | -160.8% | -52.4% |
1 y1 year | +110.8% | -114.1% | -79.9% |
5 y5 years | - | - | - |
LXEO EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -10.5% | -0.61 | +183.6% | |
3 m | 3-month | 0.57 | -10.5% | -1.56 | +132.7% |
6 m | 6-month | 0.57 | -10.5% | -2.93 | +117.4% |
1 y | 1-year | 0.57 | -10.5% | -6.45 | +107.9% |
3 y | 3-year | 0.57 | -10.5% | -6.45 | +107.9% |
5 y | 5-year | 0.57 | -10.5% | -6.45 | +107.9% |
alltime | all time | 0.57 | -10.5% | -6.45 | +107.9% |
Lexeo Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | 0.51(-160.7%) |
Date | Value |
---|---|
2024 | -0.84(-78.2%) |
2023 | -3.85 |
FAQ
- What is Lexeo Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Lexeo Therapeutics?
- What is LXEO EV/EBITDA year-to-date change?
- What is Lexeo Therapeutics EV/EBITDA year-on-year change?
What is Lexeo Therapeutics EV/EBITDA?
The current EV/EBITDA of LXEO is 0.51
What is the all time high EV/EBITDA for Lexeo Therapeutics?
Lexeo Therapeutics all-time high EV/EBITDA is 0.57
What is LXEO EV/EBITDA year-to-date change?
Lexeo Therapeutics EV/EBITDA has changed by +1.35 (+160.71%) since the beginning of the year
What is Lexeo Therapeutics EV/EBITDA year-on-year change?
Over the past year, LXEO EV/EBITDA has changed by +5.25 (+110.76%)